Metadherin plays an important role in inducing epithelial-mesenchymal transformation (EMT), proliferation, and invasion of tumor cells, promoting treatment resistance and mesenchymal hypercytosis while increasing the vulnerability of tumor cells to ferroptosis inducers, especially GPX-4 inhibitors. The gene discussed is MTDH; the disease is neoplasm.